lactic acid and krn 7000

lactic acid has been researched along with krn 7000 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Betbeder, D; Bialecki, E; Chang, J; Ehret, C; Faveeuw, C; Fontaine, J; Fournel, S; Frisch, B; Heurtault, B; Krieger, V; Macho Fernandez, E; Rodriguez, F; Trottein, F; Werkmeister, E	1
Bershteyn, A; Crespo, MP; Hanson, MC; Irvine, DJ; Li, AV; Moon, JJ; Suh, H	1

Other Studies

2 other study(ies) available for lactic acid and krn 7000

Article	Year
Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles. International journal of pharmaceutics, 2012, Feb-14, Volume: 423, Issue:1 Topics: Animals; Antigen Presentation; Antineoplastic Agents; Cell Proliferation; Clathrin; Coculture Techniques; Dendritic Cells; Drug Carriers; Endocytosis; Galactosylceramides; Interferon-gamma; Interleukin-2; Interleukin-4; Killer Cells, Natural; Lactic Acid; Leukocytes, Mononuclear; Liver; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Microspheres; Nanoparticles; Natural Killer T-Cells; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spleen; Static Electricity; Surface Properties	2012
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine. Journal of controlled release : official journal of the Controlled Release Society, 2012, Feb-10, Volume: 157, Issue:3 Topics: Adjuvants, Immunologic; Animals; Antigens; Biomimetics; Cells, Cultured; Dendritic Cells; Female; Galactosylceramides; Immunoglobulin G; Lactic Acid; Lipid A; Lipids; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; T-Lymphocytes; Vaccines, Subunit	2012

Article

Year

Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.

International journal of pharmaceutics, 2012, Feb-14, Volume: 423, Issue:1

Topics: Animals; Antigen Presentation; Antineoplastic Agents; Cell Proliferation; Clathrin; Coculture Techniques; Dendritic Cells; Drug Carriers; Endocytosis; Galactosylceramides; Interferon-gamma; Interleukin-2; Interleukin-4; Killer Cells, Natural; Lactic Acid; Leukocytes, Mononuclear; Liver; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Microspheres; Nanoparticles; Natural Killer T-Cells; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spleen; Static Electricity; Surface Properties

2012

Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.

Journal of controlled release : official journal of the Controlled Release Society, 2012, Feb-10, Volume: 157, Issue:3

Topics: Adjuvants, Immunologic; Animals; Antigens; Biomimetics; Cells, Cultured; Dendritic Cells; Female; Galactosylceramides; Immunoglobulin G; Lactic Acid; Lipid A; Lipids; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; T-Lymphocytes; Vaccines, Subunit

2012